Endometrial Cancer
📧 Sign up to get email alerts when something new happens for Endometrial Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-24Clinical Trial Update: Alternate Day Fasting After Surgery for Patients Undergoing Chemotherapy [NA]
A clinical trial is evaluating alternate-day fasting after surgery for patients undergoing chemotherapy for ovarian and endometrial (uterine…
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies [Phase 1, Phase 2]
AZD8205 is being studied in a Phase I/IIa trial as a single agent or in combination for advanced/metastatic solid tumors. Recruitment is ong…
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Using Reiki Therapy to Improve Symptoms Associated With Brachytherapy in Patients With Gynecological Malignancies [Phase 2]
This Phase 2 clinical trial is evaluating Reiki therapy to improve symptoms associated with brachytherapy in gynecologic cancers. The study …
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Advancing Care Coordination Between Cancer and Primary Care Teams for Complex Cancer Survivors [NA]
A Rutgers-sponsored clinical trial aims to improve coordination between cancer care teams and primary care for complex cancer survivors. The…
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors [Phase 1]
Open-label Phase 1 study evaluating BL-M07D1 in HER2-expressing malignant solid tumors, with recruitment across several tumor types includin…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations [Phase 1, Phase 2]
Phase 1/2 trial of TER-2013 in solid tumors harboring AKT/PI3K/PTEN alterations is currently recruiting to assess safety and preliminary eff…
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: A Phase 1 First-In-Human Study of the Anti-CD73 IPH5301 Alone or in Combination With Chemotherapy and Trastuzumab in Patients With Advanced Solid Tumors [Phase 1]
A Phase 1 first-in-human study of IPH5301, an anti-CD73 antibody, given alone or with chemotherapy and trastuzumab, in patients with advance…
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: Prehabilitation in Gynaecological Cancer Patients [Phase 3]
This is an update on a Phase 3 clinical trial evaluating prehabilitation in gynecologic cancer patients (ovarian and endometrial cancer) tha…
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03) [Phase 2]
AstraZeneca's Dato-DXd is being studied as a single agent and in combination with other anti-cancer drugs in an ongoing Phase 2 trial for ad…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Paclitaxel Therapeutic Drug Monitoring in Cancer Patients
Clinical trial update on paclitaxel therapeutic drug monitoring in cancer patients; the study is currently suspended.
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: A Study of Elacestrant Alone or in Combination With Abemaciclib in People With Endometrial Cancer [Phase 2]
Phase 2 study exploring elacestrant alone or with abemaciclib in endometrial cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors [Phase 1, Phase 2]
ART0380 is being studied in a Phase 1/2 trial for various advanced or metastatic solid tumors and the study is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors [Phase 1]
Phase 1 safety and tolerability study of XmAb541 in advanced solid tumors is currently recruiting, investigating ovarian cancer, endometrial…
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: A Study of MUC16-Directed Antibody Drug Conjugate HWK-016 in Participants With Advanced Solid Tumors. [Phase 1]
This clinical trial update outlines a Phase 1 study of HWK-016, a MUC16-directed antibody-drug conjugate, in participants with advanced soli…
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: Refining Fertility-sparing Treatment in Endometrial Carcinoma Based on Molecular Classification [Phase 2, Phase 3]
A Phase 2/Phase 3 clinical trial is investigating fertility-sparing treatment for endometrial cancer guided by molecular classification, cur…
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE) [Phase 1, Phase 2]
PMV Pharmaceuticals is evaluating PC14586 in a Phase 1/2 trial for advanced solid tumors harboring the TP53 Y220C mutation. The study is cur…
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors [Phase 1, Phase 2]
A Mayo Clinic-sponsored phase 1/2 trial evaluating a personalized neoantigen peptide-based vaccine in combination with pembrolizumab for adv…
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors [Phase 1]
Phase 1 study evaluating NKT5097 in adults with advanced or metastatic solid tumors, including various breast cancer subtypes and gynecologi…
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: PROton Therapy for Post Surgical Treatment of GYNecologic Cancer [Phase 2]
A Phase 2 clinical trial evaluating proton therapy after surgery for gynecologic cancers (cervical, uterine/endometrial cancer) is currently…
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform
This clinical trial update describes the use of a live tumor diagnostic platform to evaluate immune checkpoint inhibitor responses across mu…
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: Talazoparib and Radiation Therapy in Treating Patients With Locally Recurrent Gynecologic Cancers [Phase 1]
This Phase 1 clinical trial is evaluating talazoparib in combination with radiation therapy for locally recurrent gynecologic cancers, inclu…
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: A Study to Investigate GSK5733584 Compared With Chemotherapy in Participants With Recurrent Endometrial Cancer (BEHOLD-Endometrial01) [Phase 3]
Phase 3 clinical trial to compare GSK5733584 with chemotherapy in recurrent endometrial cancer. Recruitment has not yet begun.
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: Niraparib and Copanlisib in Treating Patients With Recurrent Endometrial, Ovarian, Primary Peritoneal, or Fallopian Tube Cancer [Phase 1]
This document describes a Phase 1 trial evaluating the combination of niraparib and copanlisib in patients with recurrent endometrial, ovari…
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: Phase I Trial Testing the Safety and Tolerability of Chemoradiation Followed by Chemotherapy + Dostarlimab for Stage IIIC, Node Positive, Endometrial Cancer [Phase 1]
Phase I trial update evaluating safety and tolerability of chemoradiation followed by chemotherapy plus dostarlimab in stage IIIC, node-posi…
-
CLINICAL_TRIALS research · 2026-03-09Clinical Trial Update: Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors [Phase 1]
A Phase 1 clinical trial from AstraZeneca evaluating a KRAS G12D-targeted TCR-T cell therapy in adults with unresectable, advanced, or metas…